GB9414902D0 - Methods - Google Patents

Methods

Info

Publication number
GB9414902D0
GB9414902D0 GB9414902A GB9414902A GB9414902D0 GB 9414902 D0 GB9414902 D0 GB 9414902D0 GB 9414902 A GB9414902 A GB 9414902A GB 9414902 A GB9414902 A GB 9414902A GB 9414902 D0 GB9414902 D0 GB 9414902D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9414902A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Priority to GB9414902A priority Critical patent/GB9414902D0/en
Publication of GB9414902D0 publication Critical patent/GB9414902D0/en
Priority to CZ1997209A priority patent/CZ286482B6/en
Priority to NZ290974A priority patent/NZ290974A/en
Priority to EP95928072A priority patent/EP0804201A4/en
Priority to AU31909/95A priority patent/AU684384B2/en
Priority to CA002195778A priority patent/CA2195778A1/en
Priority to MX9700626A priority patent/MX9700626A/en
Priority to HU9700201A priority patent/HUT77379A/en
Priority to JP8505798A priority patent/JPH10503202A/en
Priority to US08/507,487 priority patent/US5786376A/en
Priority to KR1019970700433A priority patent/KR970704446A/en
Priority to CN95195052A priority patent/CN1157564A/en
Priority to BR9508332A priority patent/BR9508332A/en
Priority to PCT/US1995/008915 priority patent/WO1996003126A1/en
Priority to ZA956098A priority patent/ZA956098B/en
Priority to NO19970284A priority patent/NO310096B1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB9414902A 1994-07-23 1994-07-23 Methods Pending GB9414902D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods
PCT/US1995/008915 WO1996003126A1 (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes
MX9700626A MX9700626A (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes.
JP8505798A JPH10503202A (en) 1994-07-23 1995-07-14 Treatment of opportunistic infections with azaspirans
EP95928072A EP0804201A4 (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes
AU31909/95A AU684384B2 (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes
CA002195778A CA2195778A1 (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes
CZ1997209A CZ286482B6 (en) 1994-07-23 1995-07-14 Medicament for treating casual infections in mammals including human beings
HU9700201A HUT77379A (en) 1994-07-23 1995-07-14 Use of azaspirane derivatives for treating accustomed infections
NZ290974A NZ290974A (en) 1994-07-23 1995-07-14 Treatment of opportunistic infections with axaspirane compounds
US08/507,487 US5786376A (en) 1994-07-23 1995-07-14 Methods of treating opportunistic infections with azaspiranes
KR1019970700433A KR970704446A (en) 1994-07-23 1995-07-14 Treatment of opportunistic infections with azaspirane (Treatment of opportunistic infections with azaspiranes)
CN95195052A CN1157564A (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes
BR9508332A BR9508332A (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspirans
ZA956098A ZA956098B (en) 1994-07-23 1995-07-21 Method of treating opportunistic infections by administration of substituted azaspirane compounds
NO19970284A NO310096B1 (en) 1994-07-23 1997-01-22 Use of azaspirans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods

Publications (1)

Publication Number Publication Date
GB9414902D0 true GB9414902D0 (en) 1994-09-14

Family

ID=10758802

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9414902A Pending GB9414902D0 (en) 1994-07-23 1994-07-23 Methods

Country Status (15)

Country Link
EP (1) EP0804201A4 (en)
JP (1) JPH10503202A (en)
KR (1) KR970704446A (en)
CN (1) CN1157564A (en)
AU (1) AU684384B2 (en)
BR (1) BR9508332A (en)
CA (1) CA2195778A1 (en)
CZ (1) CZ286482B6 (en)
GB (1) GB9414902D0 (en)
HU (1) HUT77379A (en)
MX (1) MX9700626A (en)
NO (1) NO310096B1 (en)
NZ (1) NZ290974A (en)
WO (1) WO1996003126A1 (en)
ZA (1) ZA956098B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (en) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N, n-diethyl-8,8-dipropyl-2-azaspiro (4,5) decane-2-propan amine dimaleate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (en) * 1991-06-07 1999-06-30 Smithkline Beecham Corp IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE

Also Published As

Publication number Publication date
CZ20997A3 (en) 1997-10-15
CA2195778A1 (en) 1996-02-08
AU684384B2 (en) 1997-12-11
CN1157564A (en) 1997-08-20
HUT77379A (en) 1998-04-28
EP0804201A4 (en) 2000-04-26
AU3190995A (en) 1996-02-22
EP0804201A1 (en) 1997-11-05
MX9700626A (en) 1997-05-31
NO970284L (en) 1997-03-19
NZ290974A (en) 1999-08-30
CZ286482B6 (en) 2000-04-12
KR970704446A (en) 1997-09-06
NO970284D0 (en) 1997-01-22
WO1996003126A1 (en) 1996-02-08
JPH10503202A (en) 1998-03-24
ZA956098B (en) 1996-05-23
HU9700201D0 (en) 1997-04-28
BR9508332A (en) 1997-11-04
NO310096B1 (en) 2001-05-21

Similar Documents

Publication Publication Date Title
DE69530493D1 (en) Ablationsgerät
DE69531947D1 (en) Ausbreitbare ringprothese
DE69512030D1 (en) Cerebral-dilator
GB9520261D0 (en) Bisresorcinyltriazines
EP0696731A3 (en) Cytoanalyzer
DE59503739D1 (en) Polymer-sensor
DE69502271D1 (en) Afterabtrennung
DE69511086D1 (en) Pyrimidinderivate
DE69429543D1 (en) Koagulationszange
DE69504528D1 (en) Quenchkühler
DE59503634D1 (en) Friercontainer
EP0701109A3 (en) Watermeter
DE69512382D1 (en) Deodorierte thermoplaste
DE59509661D1 (en) Heterocyclylbenzonitrile
EP0711710A3 (en) Box-pallet
DE69517886D1 (en) Spiropyranverbindung
DE69517588D1 (en) Gekühlter transportcontainer
AU122938S (en) Breadbox
DE69508761D1 (en) Haloalkylierungsverfahren
GB2289889B (en) Spiles
DE69506730D1 (en) Differentialer antriebsmechanismus
DE69527047D1 (en) Bisazoverbindung
DE59508136D1 (en) Phenylthio-oxazolin-derivate
GB9414902D0 (en) Methods
DE59510739D1 (en) N-cyanoaryl-stickstoffheterocyclen